Clinical Trial Update: Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy [Phase 1]

View source ↗

Summary

Clinical trial update on IMC-1121B in patients with advanced solid tumors not responding to standard therapy; this Phase 1 study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• IMC-1121B

Snippet

Sponsor: Eli Lilly and Company | Conditions: Cancer | Phase 1 | Status: COMPLETED